Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Exicure Inc (NQ: XCUR ) 0.3020 -0.0005 (-0.17%) Streaming Delayed Price Updated: 12:50 PM EDT, Jul 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Exicure Inc < Previous 1 2 3 4 5 6 Next > Exicure, Inc. Reports First Quarter 2024 Financial Results June 17, 2024 From Exicure, Inc. Via Business Wire Exicure, Inc. Reports Full Year 2023 Financial Results June 06, 2024 From Exicure, Inc. Via Business Wire Exicure, Inc. Received Nasdaq Notice of a Delisting Determination May 23, 2024 From Exicure, Inc. Via Business Wire Exicure, Inc. Reports Third Quarter 2023 Financial Results May 16, 2024 From Exicure, Inc. Via Business Wire Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K April 22, 2024 From Exicure, Inc. Via Business Wire Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis February 05, 2024 From Exicure, Inc. Via Business Wire Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q November 28, 2023 From Exicure, Inc. Via Business Wire Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors August 23, 2023 From Exicure, Inc. Via Business Wire Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update August 11, 2023 From Exicure, Inc. Via Business Wire Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update July 14, 2023 From Exicure, Inc. Via Business Wire Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives May 26, 2023 From Exicure, Inc. Via Business Wire Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q May 19, 2023 From Exicure, Inc. Via Business Wire Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld May 04, 2023 From Exicure, Inc. Via Business Wire Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors April 27, 2023 From Exicure, Inc. Via Business Wire Exicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate Update March 27, 2023 From Exicure, Inc. Via Business Wire Exicure, Inc. Announces Closing of Private Placement Transaction with CBI USA, Inc. and Changes to the Board of Directors February 24, 2023 From Exicure, Inc. Via Business Wire Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements December 14, 2022 From Exicure, Inc. Via Business Wire Exicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update November 14, 2022 From Exicure, Inc. Via Business Wire Exicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic Alternatives September 26, 2022 From Exicure, Inc. Via Business Wire Exicure Announces Presentation at Chardan’s 6th Annual Genetic Medicines Conference September 01, 2022 From Exicure, Inc. Via Business Wire Exicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress August 15, 2022 From Exicure, Inc. Via Business Wire Exicure, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement July 20, 2022 From Exicure, Inc. Via Business Wire Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split June 29, 2022 From Exicure, Inc. Via Business Wire Exicure, Inc. Announces Adjournment of Annual Meeting of Stockholders May 27, 2022 From Exicure, Inc. Via Business Wire Exicure Announces Presentation at 2022 H.C. Wainwright Global Life Sciences Conference May 17, 2022 From Exicure, Inc. Via Business Wire Exicure, Inc. Reports First Quarter 2022 Financial Results and Corporate Progress May 16, 2022 From Exicure, Inc. Via Business Wire Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Premium May 10, 2022 From Exicure, Inc. Via Business Wire Exicure to Present at Upcoming TIDES USA Oligonucleotide & Peptide Therapeutics Conference May 09, 2022 From Exicure, Inc. Via Business Wire Exicure, Inc. (NASDAQ:XCUR) Long Term Investor Notice: Investigation of Potential Wrongdoing April 19, 2022 San Diego, CA -- (SBWIRE) -- 04/19/2022 -- An investigation was announced for long-term investors in shares of Exicure, Inc. (NASDAQ:XCUR) concerning potential breaches of fiduciary duties by certain... Via SBWire Exicure, Inc. Reports Full Year 2021 Financial Results and Corporate Progress March 25, 2022 From Exicure, Inc. Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.